Open AccessAtypical mycobacterial infections – management and when to treat
Author(s) -
Laura Gill,
Catherine Dominic,
Simon Tiberi
Publication year - 2021
Publication title -
current opinion in pulmonary medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.937
H-Index - 75
eISSN - 1531-6971
pISSN - 1070-5287
DOI - 10.1097/mcp.0000000000000764
Subject(s) - medicine , clofazimine , intensive care medicine , nontuberculous mycobacteria , bedaquiline , tuberculosis , disease , rifabutin , population , immunology , mycobacterium tuberculosis , pathology , mycobacterium , leprosy , clarithromycin , environmental health , helicobacter pylori
Infections caused by nontuberculous mycobacteria (NTM) are increasing for several reasons, including diagnostic advances, increased awareness and a larger at-risk population. NTM pulmonary disease is surpassing tuberculosis (TB) in some low incidence areas. This review summarizes the latest literature and guidelines and aims to be a concise source outlining treatment and management of NTM lung infections, integrating established treatment paradigms with novel pharmacological interventions.